Clinical Trials Browser

Phase 1 × Adenocarcinoma × talimogene laherparepvec × Clear all

NCT00402025 2016-04-15

Talimogene Laherparepvec in Patients With Unresectable Pancreatic Cancer

Phase 1 Completed

17 enrolled 14 charts

Gastrointestinal

Adenocarcinoma, Neoplasm Metastasis, Pancreatic Neoplasms